Glibenclamide nanosuspension inhaler: development, in vitro and in vivo assessment-Reference-Cited by-同舟云学术

Glibenclamide nanosuspension inhaler: development, in vitro and in vivo assessment

Published:2020-04-20 Issue:5 Volume:46 Page:762-774
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Hashem Fahima M.¹,Abd Allah Fathy I.²³,Abdel-Rashid Rania S.¹,Hassan Abdelsabour A. A.²³⁴⁵

Affiliation:

1. Pharmaceutics Department, Faculty of Pharmacy, Helwan University, Cairo, Egypt;

2. International Center for Bioavailability, Pharmaceutical and Clinical Research (ICBR), Cairo, Egypt;

3. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar university, Cairo, Egypt;

4. Metered Dose Inhaler Department (MDI), Cairo, Egypt;

5. Arab Drug Company for pharmaceuticals and chemical industries (ADCO), Cairo, Egypt

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2020.1753062

Reference66 articles.

1. Hernandez-Kirstein N. Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia [Dissertation]. The Department of Biology, Chemistry and Pharmacy, Freie Universität Berlin; 2006.

2. Process, Physicochemical Characterization and In-Vitro Assessment of Albendazole Microcrystals

3. Nanodispersions for Drug Delivery

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formulation, optimization and full characterization of mirtazapine loaded aquasomes: a new technique to boost antidepressant effects;Drug Development and Industrial Pharmacy;2024-02-28

2. Nanosuspension-Based Drug Delivery Systems for Topical Applications;International Journal of Nanomedicine;2024-01

3. Optimizing the Current Type 2 Diabetes Antidiabetics with Nanotechnologies: Where Do We Stand?;Nanotechnology for Diabetes Management;2022-09-19

4. Glibenclamide–malonic acid cocrystal with an enhanced solubility and bioavailability;Drug Development and Industrial Pharmacy;2022-08-03

5. Spray dried inhalable ivacaftor co-amorphous microparticle formulations with leucine achieved enhanced in vitro dissolution and superior aerosol performance;International Journal of Pharmaceutics;2022-06